answer:LTI 1.3 Integration: LTI (Learning Tools Interoperability) 1.3 is a standard developed by IMS Global Learning Consortium. It allows third-party learning applications to integrate with Learning Management Systems (LMS). This integration enables a seamless user experience where the LMS and the third-party application can share data securely. Redirect URL: This is the URL where the user is sent after a successful authentication. It's where the third-party application sends the user after they have been authenticated, and it's typically the main page or dashboard of the application. Target Link URI: This is the specific location within the tool provider's system where the LMS will send the user. It's essentially the destination within the third-party application that the LMS is linking to. This could be a specific course, a particular resource, or any other specific location within the third-party application. OpenID Connect URL: OpenID Connect is a simple identity layer on top of the OAuth 2.0 protocol, which allows computing clients to verify the identity of an end-user based on the authentication performed by an authorization server. The OpenID Connect URL is the endpoint in the third-party application that handles these authentication requests. In summary, the Redirect URL and Target Link URI are used to direct the user to the correct location within the third-party application, while the OpenID Connect URL is used for handling the authentication of the user.

answer:Of course! Here's a summary of the accomplishments of the University of Kentucky Society of Physics Students (SPS) chapter and their recent awards: * The UK SPS chapter has won an Outstanding Chapter Award and a Chapter Research Award from the SPS National Office. * The Outstanding Chapter Award recognizes chapters for high levels of interaction with the campus community, the professional physics community, the public, and with SPS national programs. This is the second time the UK chapter has received this award, but it has been almost 25 years since UK was initially recognized as a top-tier student-led physical sciences organization. * The Chapter Research Award is a competitive financial grant for a yearlong research project. The UK chapter's proposal, "Data Analysis and Accuracy: Small Supercomputer versus a Desktop Dinosaur," was selected from the top five percent of submissions and will provide funding for building a mini-supercomputer following the Tiny Titan building plan from Oak Ridge National Lab. * The chapter's president, Dany Walker, expressed excitement about the recognition and the opportunity to showcase the supercomputer during the SPS Open Lab Day this spring. * The UK SPS chapter is a professional and social organization for physics majors and minors, as well as students with a general interest in physics. The chapter hosts interactive presentations and open lab days to promote education in physics and showcase research occurring in the Department of Physics and Astronomy.

answer:To kill a player if they touch a part in Roblox using Lua code, you can use the following script: ```lua -- Place this script inside the part you want to use as the trigger local function onPartTouched(part) local player = game.Players:GetPlayerFromCharacter(part.Parent) if player then player.Character:BreakJoints() end end script.Parent.Touched:Connect(onPartTouched) ``` This script creates a function called `onPartTouched` that is triggered whenever the part is touched by any other part or character. Inside the function, it checks if the touched object is a player's character. If it is, it breaks the joints of the player's character, effectively killing them. Make sure to place this script inside the part you want to use as the trigger.

answer:LUAD, or Lung Adenocarcinoma, is a type of lung cancer that originates in the glands that line the inside of the lungs' airways. It's the most common type of lung cancer in non-smokers and is often found in the outer parts of the lung. LUAD can be asymptomatic in its early stages, but symptoms such as coughing, chest pain, weight loss, and shortness of breath may appear as the disease progresses. Treatment options typically include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these.